Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 15.06% vs 4.61% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 30.89% vs 16.94% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 15.20% vs 4.75% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 23.81% vs -52.27% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Lincoln Pharma. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is -5.34% vs 12.60% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 15.06% vs 4.61% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 211.52% vs -59.34% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 30.89% vs 16.94% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 10.38% vs 5.34% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 15.20% vs 4.75% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is -3.70% vs -10.00% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 23.81% vs -52.27% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






